Effect of conjugated linoleic acid (CLA) on lipid profile and liver histology in laboratory rats fed high-fructose diet

Environmental Toxicology and Pharmacology

Volumn 30, Issue 3, 2010, Pages 245-250

  Kostogrys, Renata B ^a   Pisulewski, Paweł M ^a  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

CLA; Fructose; Lipid profile; Liver; MDA; Rats

Indexed keywords

CONJUGATED LINOLEIC ACID; FRUCTOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIET THERAPY; FATTY LIVER; LIPID BLOOD LEVEL; LIVER HISTOLOGY; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77957374047     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.06.006     Document Type: Article

References (40)

1. Abdullah M.M., Xu Z., Pierce G.N., Moghadasian M.H. The effects of simultaneous administration of dietary conjugated linoleic acid and telmisartan on cardiovascular risks in rats. Lipids 2007, 42:855-864.
2. Arbonés-Mainar J.M., Navarro M.A., Acín S., Guzmán M.A., Arnal C., Surra J.C., Carnicer R., Roche H.M., Osada J Trans-10, cis-12- and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J. Nutr. 2006, 136:353-359.
3. Basciano H., Federico L., Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metab. 2005, 21:2-5.
4. Belury MA Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J. Nutr. 2002, 132:2995-2998.
5. Benado M., Alcantara C., de la Rosa R., Ambrose M., Mosier K., Kern M. Effects of various levels of dietary fructose on blood lipids of rats. Nutr. Res. 2004, 24:565-571.
6. Bergheim I., Weber S., Vos M., Krämer S., Volynets V., Kaserouni S., McClain C.J., Bischoff S.C. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 2008, 48(6):983-992.
7. Bezerra R.M., Ueno M., Silva M.S., Tavares D.Q., Carvalho C.R., Saad M.J. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J. Nutr. 2000, 130(6):1531-1535.
8. Busserolles J., Gueux E., Rock E., Mazur A., Rayssiguier Y. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J. Nutr. 2002, 132(11):3379-3382.
9. Cho H.J., Kim E.J., Lim S.S., Kim M.K., Sung M.K., Kim J.S., Park J.H.Y. Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. J. Nutr. 2006, 136:893-898.
10. Elliott S.S., Keim N.L., Stern J.S., Teff K., Havel P.J. Fructose, weight gain, and the insulin resistance syndrome. Am. J. Clin. Nutr. 2002, 76(5):911-922.
11. Evans M., Brown J., McIntosh M. Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J. Nutr. Biochem. 2002, 13:508-516.
12. Fernandez M.L., West K.L. Mechanisms by which dietary fatty acids modulate plasma lipids. J. Nutr. 2005, 135:2075-2078.
13. Field C.J., Schley P.D. Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. Am. J. Clin. Nutr. 2004, 79:1190S-1198S.
14. Franczyk-Żarów M., Kostogrys R.B., Szymczyk B., Jawień J., Gajda M., Cichocki T., Wojnar L., Chłopicki S., Pisulewski P.M. Functional effects of eggs, naturally enriched with conjugated linoleic acid (CLA), on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low density lipoprotein receptor double-knockout mice (apoE/LDLR -/-). Br. J. Nutr. 2008, 99:49-58.
15. Gaullier J.M., Halse J., Hoye K., Kristiansen K., Fagertun H., Vik H., Gudmundsen O. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J. Nutr. 2005, 135:778-784.
16. Getz G.S., Reardon C.A. Nutrition and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2499-2506.
17. Girard A., Madani S., Boukortt F., Cherkaoui-Malki M., Belleville J., Prost J. Fructose-enriched diet modifies antioxidant status and lipid metabolism in spontaneously hypertensive rats. Nutrition 2006, 22(7-8):758-766.
18. Griinari J.M., Bauman D.E. Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk in ruminants. Advances in Conjugated Linoleic Acid Research 1999, AOCS Press, Champaign, IL, pp. 180-199. M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza, G.J. Nelson (Eds.).
19. Grundy S.M., Denke M.A. Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 1990, 31:1149-1172.
20. Howard B.V., Wylie-Rosett J. Sugar and cardiovascular disease: a statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2002, 23(106):523-527.
21. Kelley G.L., Allan G., Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004, 145(2):548-555.
22. Kiernan JA Histological & Histochemical Methods Theory & Practice 1990, Pergamon Press, Great Britain BPCC, Wheatons Ltd., Exeter, pp. 413-421. 2nd ed.
23. Kloss R., Linscheid J., Johnson A., Lawson B., Edwards K., Linder T., Stocker K., Petitte J., Kern M. Effects of conjugated linoleic acid supplementation on blood lipids and adiposity of rats fed diets rich in saturated versus unsaturated fat. Pharmacol. Res. 2005, 51:503-507.
24. Kritchevsky D., Tepper S.A., Wright S., Tso P., Czarnecki S.K. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J. Am. Coll. Nutr. 2000, 19:472S-477S.
25. Kritchevsky D., Tepper S.A., Wright S., Czarnecki S.K. Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr. Res. 2002, 22:1275-1279.
26. Merat S., Casanada F., Sutphin M., Palinski W., Reaven P.D. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1223-1230.
27. Noone E.J., Roche H.M., Nugent A.P., Gibney M.J. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br. J. Nutr. 2002, 88:243-251.
28. O'Shea M., Bassaganya-Riera J., Mohede I.C.M. Immunomodulatory properties of conjugated linoleic acid. Am. J. Clin. Nutr. 2004, 79:1199S-1206S.
29. Park Y., Pariza M.W. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Res. Int. 2007, 40:311-323.
30. Purushotham A., Shrode G.E., Wendel A.A., Liu L.F., Belury M.A. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats. J. Nutr. Biochem. 2007, 18:676-684.
31. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123:1939-1951.
32. Santos-Zago L.F., Botelho A.P., de Oliveira A.C. Supplementation with commercial mixtures of conjugated linoleic acid in association with vitamin E and the process of lipid autoxidation in rats. Lipids 2007, 42(9):845-854.
33. Terpstra A.H., Javadi M., Beynen A.C., Kocsis S., Lankhorst A.E., Lemmens A.G., Mohede I.C. Dietary conjugated linoleic acids as free fatty acids and triacylglycerols similarly affect body composition and energy balance in mice. J. Nutr. 2003, 133:3181-3186.
34. Toomey S., Harhen B., Roche H.M., Fitzgerald D., Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 2006, 187:40-49.
35. Tricon S., Burdge G.C., Kew S., Banerjee T., Russell J.J., Jones E.L., Grimble R.F., Williams C.M., Yaqoob P., Calder P.C. Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am. J. Clin. Nutr. 2004, 80:614-620.
36. Tricon S., Burdge G.C., Kew S., Banerjee T., Russell J.J., Grimble R.F., Williams ChM, Calder P.C., Yaqoob P. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am. J. Clin. Nutr. 2004, 80:1626-1633.
37. Valeille K., Gripois D., Blouquit M.F., Souidi M., Riottot M., Bouthegourd J.C., Serougne C., Martin J.C. Lipid atherogenic risk markers can be more favourably influenced by the cis-9 trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Br. J. Nutr. 2004, 91:191-199.
38. Wang Y., Jones P.J.H. The role of conjugated linoleic acid in human health dietary conjugated linoleic acid and body composition. Am. J. Clin. Nutr. 2004, 79:1153S-1158S.
39. Yeung Ch.H., Yang L., Huang Y. Dietary conjugated linoleic acid mixture affects the activity of intestinal acyl coenzyme A: cholesterol acyltransferase in hamsters. Br. J. Nutr. 2000, 84:935-941.
40. Yotosumoto H., Hara E., Naka S. 10 trans, 12 cis linoleic acid reduces apolipoprotein B secretion in HepG2 cells. Food Res. Int. 1999, 31:403-409.